| Recruitment status | Completed |
| Trial start date | 21 Oct 2011 |
| Trial end date | 15 Oct 2012 |
| Sex | Female and Male |
| Age range | 18 to 75 years |
| Sarcoma type |
A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma.
This trial is to evaluate the clinical efficacy of a drug known as palifosfamide-tris administered with doxorubicin in combination, compared with doxorubicin administered with placebo in front-line patients diagnosed with metastatic soft tissue sarcoma (STS)
ZIOPHARM
| Hospital | Suburb / Town | Contact name | Phone | Recruitment status | |
| Peter MacCallum Cancer Centre, Medical Oncology | East Melbourne | Ms Sam Ruell | sam.ruell@petermac.org | 03 9656 1111 | Closed |
Print this page
Print this page